Linked from

The 45 pages that link to Therapeutic drug monitoring, each with the reason it gives.

• PharmacokineticsRelated: Measured levels can reveal whether exposure falls within a useful range.

• Drug interactionRelated: Concentration monitoring can detect interactions that push exposure outside a safe range.

• Drug metabolismRelated: Measured concentrations can reveal unexpectedly rapid or slow metabolic handling.

• Minimum inhibitory concentrationRelated: Measured exposure can be compared with MIC when tailoring doses for selected antimicrobials.

• PharmacodynamicsRelated: Concentration measurements are useful when interpreted alongside the effects they are meant to predict.

• Therapeutic indexRelated: Monitoring helps manage medicines whose effective and toxic exposures are close.

• VancomycinRelated: Monitoring helps individualize intravenous vancomycin dosing, especially for serious infections.

• AminoglycosideRelated: Monitoring helps balance aminoglycoside exposure against kidney and ear injury.

• Antiseizure medicationRelated: Levels can guide dosing for selected medicines, though concentration alone does not predict seizure control.

• Drug toleranceRelated: Monitoring can help distinguish inadequate exposure from reduced responsiveness.

• OtotoxicityRelated: For some treatments, managing exposure can reduce risk without abandoning necessary therapy.

• ValproateRelated: Blood concentrations can help assess valproate exposure, especially when response or toxicity is uncertain.

• CarbamazepineRelated: Blood-level measurement can help assess adherence, interactions, and suspected toxicity.

• Biological half-lifeRelated: Half-life helps determine when samples reflect accumulation, steady state, or washout.

• Herb–drug interactionRelated: Monitoring can detect altered exposure when an interaction affects a medicine with measurable levels.

• LevothyroxineRelated: TSH testing helps keep replacement within an appropriate range and avoid over-treatment.

• Immunosuppressive therapyRelated: Monitoring helps balance adequate suppression against concentration-related harms for selected medicines.

• Active metaboliteRelated: Monitoring parent drug alone can misrepresent exposure when active metabolites contribute substantially.

• Azole antifungalRelated: Monitoring is useful for azoles with variable exposure, narrow therapeutic ranges, or complex interactions.

• Clinical chemistryRelated: Clinical chemistry methods can track drugs with narrow therapeutic ranges.

• CyclosporineRelated: Variable exposure and a narrow therapeutic range make cyclosporine levels clinically useful.

• DigoxinRelated: Blood concentrations can help assess digoxin exposure when interpreted alongside timing and clinical status.

• Disease-modifying antirheumatic drugRelated: Monitoring can help assess exposure or response for selected biologic treatments.

• PharmacotherapyRelated: Concentration measurements can reveal whether an individual dose needs adjustment.

• Mycophenolate mofetilRelated: Monitoring mycophenolic acid exposure can help tailor therapy in selected transplant settings.

• TacrolimusRelated: Tacrolimus has a narrow therapeutic range, so blood concentrations often guide systemic dosing.

• Mood stabilizerRelated: Lithium and valproate often require blood tests to check concentrations and support safe dosing.

• Clinical pharmacologyRelated: It adjusts treatment when measured exposure better predicts effect than a standard dose.

• InfliximabRelated: Testing can help explain loss of response and inform infliximab dose adjustments or switches.

• TheophyllineRelated: Blood-level monitoring helps keep theophylline within its narrow safe range.

• ClomipramineRelated: Blood-level measurement can help assess exposure when response or adverse effects are difficult to interpret.

• Immunosuppressive drugRelated: Monitoring helps keep levels effective while limiting toxicity for drugs with narrow dosing ranges.

• Medical testRelated: It uses repeated measurements to keep treatment effective while limiting toxicity.

• AnticonvulsantRelated: Monitoring can help optimize selected anticonvulsants with variable pharmacokinetics or narrow therapeutic ranges.

• RitonavirRelated: Concentration changes from ritonavir interactions can make monitoring or dose adjustment necessary.

• AmikacinRelated: Monitoring can help tailor amikacin exposure, especially during prolonged or high-dose treatment.

• Medical laboratoryRelated: Laboratory levels can inform dose adjustments for drugs with narrow safety margins.

• TobramycinRelated: Blood-level monitoring can guide systemic tobramycin dosing, especially during prolonged treatment.

• PhenytoinRelated: Blood-level monitoring helps manage phenytoin's narrow therapeutic range and nonlinear clearance.

• CiclosporinRelated: Variable exposure and a narrow therapeutic range make blood-level monitoring useful for ciclosporin.